Activated NOTCH2 is overexpressed in hepatoblastomas: An immunohistochemical study

Jason B. Litten, Tina T L Chen, Roger Schultz, Karl Herman, Jessica Comstock, Joshua Schiffman, Gail E. Tomlinson, Dinesh Rakheja

Research output: Contribution to journalArticle

15 Citations (Scopus)

Abstract

Hepatoblastoma is a pediatric malignancy characterized by the uncontrolled proliferation of immature hepatocytes (hepatoblasts). This disease is diagnosed primarily in children younger than 5 years and is disproportionately observed in former premature infants. Cytogenetically, hepatoblastoma is characterized by numerical aberrations, as well as unbalanced translocations involving the proximal region of chromosome 1q. The NOTCH2 gene has been mapped to this locus, and it is well established that the NOTCH gene family is an important regulator of several developmental pathways. Specifically, the NOTCH2 protein is known to delay hepatoblast maturation during early hepatic organogenesis, and the reduction of NOTCH2 expression correlates with the differentiation of hepatoblasts into hepatocytes and biliary cells in the developing liver. We hypothesized that NOTCH2 is involved in the pathogenesis of hepatoblastoma by maintaining a population of undifferentiated hepatoblasts. We studied the immunohistochemical expression of NOTCH2 and its isoforms NOTCH1, NOTCH3, and NOTCH4 and the NOTCH2 primary ligand JAGGED1 in hepatoblastomas. Compared with the normal liver, an increased level of NOTCH2 expression was seen in 22 of 24 (92%) hepatoblastomas. There was no significant staining for other NOTCH isoforms and JAGGED1 in hepatoblastomas. Therefore, we suggest that NOTCH2 expression and activation, independent of JAGGED1 expression, may contribute to the pathogenesis of hepatoblastoma. In the hepatoblastoma sinusoidal vasculature, we saw NOTCH3 and NOTCH1 expression. These observations have potential implications with regard to therapeutic targeting of the NOTCH signaling pathway in hepatoblastomas.

Original languageEnglish (US)
Pages (from-to)378-383
Number of pages6
JournalPediatric and Developmental Pathology
Volume14
Issue number5
DOIs
StatePublished - 2011

Fingerprint

Hepatoblastoma
Hepatocytes
Liver
Protein Isoforms
Organogenesis
Premature Infants
Genes
Chromosomes
Pediatrics
Staining and Labeling
Ligands

Keywords

  • Hepatoblastoma
  • Immunohistochemistry
  • Liver
  • NOTCH
  • NOTCH2

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health
  • Pathology and Forensic Medicine

Cite this

Activated NOTCH2 is overexpressed in hepatoblastomas : An immunohistochemical study. / Litten, Jason B.; Chen, Tina T L; Schultz, Roger; Herman, Karl; Comstock, Jessica; Schiffman, Joshua; Tomlinson, Gail E.; Rakheja, Dinesh.

In: Pediatric and Developmental Pathology, Vol. 14, No. 5, 2011, p. 378-383.

Research output: Contribution to journalArticle

Litten, JB, Chen, TTL, Schultz, R, Herman, K, Comstock, J, Schiffman, J, Tomlinson, GE & Rakheja, D 2011, 'Activated NOTCH2 is overexpressed in hepatoblastomas: An immunohistochemical study', Pediatric and Developmental Pathology, vol. 14, no. 5, pp. 378-383. https://doi.org/10.2350/10-09-0900-OA.1
Litten, Jason B. ; Chen, Tina T L ; Schultz, Roger ; Herman, Karl ; Comstock, Jessica ; Schiffman, Joshua ; Tomlinson, Gail E. ; Rakheja, Dinesh. / Activated NOTCH2 is overexpressed in hepatoblastomas : An immunohistochemical study. In: Pediatric and Developmental Pathology. 2011 ; Vol. 14, No. 5. pp. 378-383.
@article{c62cb63b8c6845edbb414d8738378828,
title = "Activated NOTCH2 is overexpressed in hepatoblastomas: An immunohistochemical study",
abstract = "Hepatoblastoma is a pediatric malignancy characterized by the uncontrolled proliferation of immature hepatocytes (hepatoblasts). This disease is diagnosed primarily in children younger than 5 years and is disproportionately observed in former premature infants. Cytogenetically, hepatoblastoma is characterized by numerical aberrations, as well as unbalanced translocations involving the proximal region of chromosome 1q. The NOTCH2 gene has been mapped to this locus, and it is well established that the NOTCH gene family is an important regulator of several developmental pathways. Specifically, the NOTCH2 protein is known to delay hepatoblast maturation during early hepatic organogenesis, and the reduction of NOTCH2 expression correlates with the differentiation of hepatoblasts into hepatocytes and biliary cells in the developing liver. We hypothesized that NOTCH2 is involved in the pathogenesis of hepatoblastoma by maintaining a population of undifferentiated hepatoblasts. We studied the immunohistochemical expression of NOTCH2 and its isoforms NOTCH1, NOTCH3, and NOTCH4 and the NOTCH2 primary ligand JAGGED1 in hepatoblastomas. Compared with the normal liver, an increased level of NOTCH2 expression was seen in 22 of 24 (92{\%}) hepatoblastomas. There was no significant staining for other NOTCH isoforms and JAGGED1 in hepatoblastomas. Therefore, we suggest that NOTCH2 expression and activation, independent of JAGGED1 expression, may contribute to the pathogenesis of hepatoblastoma. In the hepatoblastoma sinusoidal vasculature, we saw NOTCH3 and NOTCH1 expression. These observations have potential implications with regard to therapeutic targeting of the NOTCH signaling pathway in hepatoblastomas.",
keywords = "Hepatoblastoma, Immunohistochemistry, Liver, NOTCH, NOTCH2",
author = "Litten, {Jason B.} and Chen, {Tina T L} and Roger Schultz and Karl Herman and Jessica Comstock and Joshua Schiffman and Tomlinson, {Gail E.} and Dinesh Rakheja",
year = "2011",
doi = "10.2350/10-09-0900-OA.1",
language = "English (US)",
volume = "14",
pages = "378--383",
journal = "Pediatric and Developmental Pathology",
issn = "1093-5266",
publisher = "Society for Pediatric Pathology",
number = "5",

}

TY - JOUR

T1 - Activated NOTCH2 is overexpressed in hepatoblastomas

T2 - An immunohistochemical study

AU - Litten, Jason B.

AU - Chen, Tina T L

AU - Schultz, Roger

AU - Herman, Karl

AU - Comstock, Jessica

AU - Schiffman, Joshua

AU - Tomlinson, Gail E.

AU - Rakheja, Dinesh

PY - 2011

Y1 - 2011

N2 - Hepatoblastoma is a pediatric malignancy characterized by the uncontrolled proliferation of immature hepatocytes (hepatoblasts). This disease is diagnosed primarily in children younger than 5 years and is disproportionately observed in former premature infants. Cytogenetically, hepatoblastoma is characterized by numerical aberrations, as well as unbalanced translocations involving the proximal region of chromosome 1q. The NOTCH2 gene has been mapped to this locus, and it is well established that the NOTCH gene family is an important regulator of several developmental pathways. Specifically, the NOTCH2 protein is known to delay hepatoblast maturation during early hepatic organogenesis, and the reduction of NOTCH2 expression correlates with the differentiation of hepatoblasts into hepatocytes and biliary cells in the developing liver. We hypothesized that NOTCH2 is involved in the pathogenesis of hepatoblastoma by maintaining a population of undifferentiated hepatoblasts. We studied the immunohistochemical expression of NOTCH2 and its isoforms NOTCH1, NOTCH3, and NOTCH4 and the NOTCH2 primary ligand JAGGED1 in hepatoblastomas. Compared with the normal liver, an increased level of NOTCH2 expression was seen in 22 of 24 (92%) hepatoblastomas. There was no significant staining for other NOTCH isoforms and JAGGED1 in hepatoblastomas. Therefore, we suggest that NOTCH2 expression and activation, independent of JAGGED1 expression, may contribute to the pathogenesis of hepatoblastoma. In the hepatoblastoma sinusoidal vasculature, we saw NOTCH3 and NOTCH1 expression. These observations have potential implications with regard to therapeutic targeting of the NOTCH signaling pathway in hepatoblastomas.

AB - Hepatoblastoma is a pediatric malignancy characterized by the uncontrolled proliferation of immature hepatocytes (hepatoblasts). This disease is diagnosed primarily in children younger than 5 years and is disproportionately observed in former premature infants. Cytogenetically, hepatoblastoma is characterized by numerical aberrations, as well as unbalanced translocations involving the proximal region of chromosome 1q. The NOTCH2 gene has been mapped to this locus, and it is well established that the NOTCH gene family is an important regulator of several developmental pathways. Specifically, the NOTCH2 protein is known to delay hepatoblast maturation during early hepatic organogenesis, and the reduction of NOTCH2 expression correlates with the differentiation of hepatoblasts into hepatocytes and biliary cells in the developing liver. We hypothesized that NOTCH2 is involved in the pathogenesis of hepatoblastoma by maintaining a population of undifferentiated hepatoblasts. We studied the immunohistochemical expression of NOTCH2 and its isoforms NOTCH1, NOTCH3, and NOTCH4 and the NOTCH2 primary ligand JAGGED1 in hepatoblastomas. Compared with the normal liver, an increased level of NOTCH2 expression was seen in 22 of 24 (92%) hepatoblastomas. There was no significant staining for other NOTCH isoforms and JAGGED1 in hepatoblastomas. Therefore, we suggest that NOTCH2 expression and activation, independent of JAGGED1 expression, may contribute to the pathogenesis of hepatoblastoma. In the hepatoblastoma sinusoidal vasculature, we saw NOTCH3 and NOTCH1 expression. These observations have potential implications with regard to therapeutic targeting of the NOTCH signaling pathway in hepatoblastomas.

KW - Hepatoblastoma

KW - Immunohistochemistry

KW - Liver

KW - NOTCH

KW - NOTCH2

UR - http://www.scopus.com/inward/record.url?scp=84855399437&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84855399437&partnerID=8YFLogxK

U2 - 10.2350/10-09-0900-OA.1

DO - 10.2350/10-09-0900-OA.1

M3 - Article

C2 - 21639801

AN - SCOPUS:84855399437

VL - 14

SP - 378

EP - 383

JO - Pediatric and Developmental Pathology

JF - Pediatric and Developmental Pathology

SN - 1093-5266

IS - 5

ER -